Proactive Investors - Run By Investors For Investors

The Hydroponics Company to change name to THC Global Group Limited

The medical cannabis company is vertically integrated from 'farm to pharma'.
global map showing market access through partnerships
The company's partnerships provide market access to four continents

The Hydroponics Company Ltd (ASX:THC) will put a resolution to its shareholders to change its name to THC Global Group Limited at its upcoming annual general meeting on 15 November 2018.

The change of company name will be one of 14 resolutions put to shareholders to vote on at the meeting.

Vertical integration, from farm to pharma

THC Global is a diversified global medical cannabis business that is vertically integrated from ‘farm to pharma’.

The vertical integration begins with a growing site in northern New South Wales and a growing, research and development facility in Queensland.

It then flows through to an industry-leading biopharmaceutical manufacturing facility ready for pharma-grade production.

Finally, THC Global has established international commercial partnerships with global industry leaders across Europe, Middle East, North America and Australia.

READ: The Hydroponics Company imported medicinal cannabis products available to Australian patients

During the current December quarter, THC Global aims to complete licencing and permitting activities on existing facilities and expand its product distribution.

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full THC profile View Profile

THC Global Group Ltd Timeline

Related Articles

A cannabis facility
December 02 2018
The Vancouver-based medicinal cannabis grower’s Queensland facility will be the world's largest greenhouse cannabis operation, covering a 99-acre site
The R&D programme is intended to address the increasing prevalence of obesity and diabetes using smart siRNA
October 31 2018
The health sciences company noted that the plan was formulated at a recently held two-day intensive workshop which together leading scientific teams from the QIMR Berghofer Medical Research Institute in Brisbane and Murdoch University in Perth
medical cannabis
October 01 2018
The companies will collaborate on activities to develop cannabinoid medicines as a medical option in Chile.

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use